Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: The randomized evaluation of strategies for left ventricular dysfunction pilot study
2000
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET
2005
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Use of carvedilol in chronic heart failure: Challenges in therapeutic management
1998
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
1995
Treatment guidelines in heart failure
1998
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure
2000
Effects of Beta-Adrenergic Blockade on Survival of Patients With Chronic Heart Failure
1997
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Unstable angina: Pathogenesis, diagnosis, and treatment
1993
Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers
2008
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients
1988
Analysis of coronary blood flow velocity dynamics in angiographicaily normal and stenosed arteries before and after endolumen enlargement by angioplasty
1993
Wound repair and regeneration
2008 StandoutNature
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
2004
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
1998
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Coronary artery flow monitoring following coronary interventions
1993
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Update on recent clinical trials in congestive heart failure
2000
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
2002
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation
2002
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Heart failure disease management: a critical review
1999
Successes and failures of current treatment of heart failure
1998
High-fidelity translesional pressure gradients during percutaneous transluminal coronary angioplasty: Correlation with quantitative coronary angiography
1993
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
The Management of Chronic Heart Failure
1996
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure
2000
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
1995
Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
1997
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
2003
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements
1995
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial
2000
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Coronary flow reserve as a physiologic measure of stenosis severity
1990
Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled β-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic Dysfunctiona
2003
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
1996
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Safety and efficacy of carvedilol in severe heart failure
1997
Homocysteine and Atherothrombosis
1998 Standout
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Comparison of the Effects of AV Nodal Ablation Versus AV Nodal Modification in Patients with Congestive Heart Failure and Uncontrolled Atrial Fibrillation
1998
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Liver Transplantation in the United States, 1999-2008
2010
Intracoronary pressure and flow velocity with sensor-tip guidewires: A new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions
1993
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure
1996
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chronic Heart Failure in the United States
1998
β-Blockers in Chronic Heart Failure
2003
Early and Delayed Consequences of β 2 -Adrenergic Receptor Overexpression in Mouse Hearts
2000
Autoantibodies Activating Human β 1 -Adrenergic Receptors Are Associated With Reduced Cardiac Function in Chronic Heart Failure
1999
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
2009
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
β-Adrenergic Receptor Signaling: An Acute Compensatory Adjustment—Inappropriate for the Chronic Stress of Heart Failure?
2000
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Mechanisms and Models in Heart Failure
2005
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
1996
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
2000 StandoutNobel
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
1996
The Role of ??-Blockers in the Treatment of Cardiomyopathy and Ischaemic Heart Failure
1994
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial Infarction
1997
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation
1997
Beta-Adrenergic Blockade in Chronic Heart Failure
1998
Prognostic Value of Bisoprolol-Induced Hemodynamic Effects in Heart Failure During the Cardiac Insufficiency BIsoprolol Study (CIBIS)
1997
Clinical Effects of β-Adrenergic Blockade in Chronic Heart Failure
1998
Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography.
1994
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
1996
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Influence of β -Blockers on Mortality in Chronic Heart Failure
2000
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Is the Failing Heart Energy Starved?
2004
Common Genomic Response in Different Mouse Models of β-Adrenergic–Induced Cardiomyopathy
2003
Works of M.R. Johnson being referenced
Automated analysis of coronary arterial morphology in cineangiograms: geometric and physiologic validation in humans
1989
Heart Retransplantation
2007
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
1993
Repeat Organ Transplantation in the United States, 1996–2005
2007
Changes in cross-sectional area of the coronary lumen in the six months after angioplasty: a quantitative analysis of the variable response to percutaneous transluminal angioplasty.
1986
The effect of coronary angioplasty on coronary flow reserve.
1988
Long-term effects of cyclosporine-based immunosuppression in cardiac transplantation: the Loyola experience.
1990